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ABSTRACT The solution structure of mouse cytochrome P450 2A4 (CYP2A4), a monooxygenase of deoxysteroids, was
obtained using homology modeling and molecular dynamics. The solvent-equilibrated CYP2A4 preserves the essential features
of CYP450s. A comparison of the models CYP2A4 and CYP2A4 with testosterone bound CYP2A4/T illustrates the changes
induced by the binding of the substrate. Experimental evidence links four amino acid residues to the catalytic activity, substrate
speciﬁcity, and regioselectivity of this enzyme. Three of the four amino acids are found within contact distance of the
testosterone substrate, and therefore may control the binding of the substrate through direct interaction. Remarkably, a water
complex previously observed in x-ray crystal structure forms near the bulge in the central I helix that contains a conserved Thr.
The properties of the I helix are computed in the context of the presence or absence of ligand.
INTRODUCTION
Cytochrome P450 (CYP450) monooxygenases catalyze
biological activation and transfer of oxygen during the
synthesis of steroid hormones and the metabolism of
exogenous compounds. Metabolism of xenobiotics by
CYP450s usually reduces the toxicity and promotes
excretion of these xenobiotics. However, CYP450 inter-
actions may sometimes increase toxicity of drugs, with
lethal outcomes (Guengerich, 2001). Therefore, biomedical
researchers are greatly interested in understanding and
controlling the interactions of CYP450s with novel drugs.
The ability to screen out potentially harmful CYP450
interactions with drugs would be greatly improved by the
availability of a three-dimensional model of CYP450.
Potential drug candidates could then be tested by docking
into the modeled active site. For this task, molecular
modeling proves to be a valuable tool. Modeling not only
allows one to visualize the fold of the enzyme, but also to
examine closely the structural details underlying the
substrate-enzyme interactions. The modeling work is
facilitated by the general fold similarity that exists across
the diverse CYP450 families, including both eukaryotic and
prokaryotic CYP450s (Dai et al., 2000). In animals, more
than 40 cytochrome P450 gene families give rise to a vast
number of different CYP450s. However, certain structural
elements, especially those involved in the catalytic activity
of CYP450, are conserved throughout these families
(Williams et al., 2000a). These conserved motifs make
possible the construction of plausible molecular models of
CYP450 enzymes for which structural data is not yet
available.
In this study, we develop an equilibrated solution structure
of cytochrome P450 2A4 (CYP2A4), a 15-a-hydroxylase of
11-deoxysteroids (e.g., testosterone). CYP2A4, a mouse
enzyme, although arguably of less immediate interest for the
biomedical community than human CYP450s, has a rich
associated experimental database. It shares 83% sequence
identity with a human CYP2A6, a coumarin hydroxylase.
CYP2A6 has been shown to activate many precarcinogens
(Oscarson et al., 1998). Its murine counterpart, coumarin
hydroxylase CYP2A5, has also been implicated in cancer
(Kobliakov et al., 1993). CYP2A5 is closely related to
CYP2A4, as the sequences of the two enzymes differ by
only 11 amino acids. However, CYP2A5 exhibits a very dif-
ferent substrate speciﬁcity from that of CYP2A4. Pertinent
experimental data is summarized in Table 1. Wild-type
CYP2A5 binds and hydroxylates coumarin at position 7, and
has no detectable activity toward testosterone. This diverse
substrate speciﬁcity in two closely related enzymes illus-
trates a general theme in the functioning of CYP450
enzymes, which exhibit great substrate diversity as a group
while individually maintaining high substrate speciﬁcity.
The speciﬁcity and regioselectivity in a single enzyme are
effected by a few mutations, most probably at the active site.
Site-directed mutagenesis has been applied to identify the
speciﬁc amino acids that control this speciﬁcity. Four
residues (at positions 117, 209, 365, and 481) identiﬁed by
these methods were proposed to be located in the heme-
binding cavity, and possibly come into contact with the
substrate (Lindberg and Negishi, 1989; Iwasaki et al., 1993a
and 1993b; Negishi et al., 1996a; 1996b; 1996c). Most
strikingly, a single mutation, Phe209Leu, is required to
confer steroid 15-a-hydroxylase speciﬁcity to CYP2A5. We
aim to develop a model that will enable us to examine the
variations in the geometry of the binding pocket brought
about by these mutations, and that lead to functional
diversity between these two enzymes. The conservation of
the functional importance of residues at positions 117, 209,
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365, and 481 throughout the CYP2 family makes this study
broadly applicable to CYP450 (Negishi et al., 1996b).
The model of CYP2A4 presented here is based mainly on
two pieces of experimental evidence: the ﬁrst mammalian
x-ray crystal structure of CYP2C5, and extensive mutagen-
esis studies performed on CYP2A4 and CYP2A5 enzymes
as described above. In the absence of an x-ray crystal
structure of CYP2A4, anticipated fold similarities between
members of CYP2 families are utilized to build a three-
dimensional model of CYP2A4 in solution based on the
recently solved x-ray crystal structure of CYP2C5 at 3.0 A˚
resolution (Williams et al., 2000a). CYP2C5 is a rabbit
cytochrome, and the ﬁrst mammalian CYP450 for which an
x-ray crystal structure has been obtained. As a template for
modeling other mammalian CYP450s, it is an improvement
over the bacterial CYP450s, which were used before its
publication. It has a higher sequence identity to other
mammalian CYP450s than do bacterial CYP450s. More-
over, the fact that mammalian CYP450s are membrane
bound whereas the bacterial enzymes are soluble accounts
for some signiﬁcant structural differences (Williams et al.,
2000b). Despite these differences, bacterial CYP450 struc-
tures were useful in predicting the structure of a mammalian
CYP450. Previous studies of bacterial CYP450s point to
the recurring motifs in the three-dimensional structure of
all CYP450s. Six substrate recognition sites common to
bacterial and mammalian CYP450s were identiﬁed (Gotoh,
1992). Some important trends emerged, in particular, of three
early bacterial CYP450s: CYP450cam, CYP450terp, and
CYP450bm3 (Hasemann et al., 1995). The most striking
similarity ﬁrst observed among the three bacterial structures
and extended to the mammalian CYP450s is the conserved
region in the core of the protein. The core contains the central
and carboxy terminal part of the I helix, the L and J helices,
and the residues around the cysteine that ligates the heme,
referred to as the Cys-pocket. The most ﬂexible parts of the
structures are located closer to the surface of the protein, and
include the F, G, A, and B helices. In particular, the FG loop
is expected to be extremely ﬂexible, inasmuch as it varies in
length among CYP450s. The general features of CYP2C5
and the extent to which they were conserved in the CYP2A4
model will be discussed later. The most relevant feature (for
the purposes of our work) that should be emphasized here is
the geometry of the active site surrounding the heme in
CYP2C5. In our sequence alignment of CYP2C5 and
CYP2A4 (Fig. 1), four of the amino acids that line the
active site in CYP2C5 (Ala-113, Val-205, Leu-358, and Val-
474) map to the four residues in CYP2A4 that were
experimentally determined to control substrate speciﬁcity
(Ala-117, Val-209, Leu-365, and Val-481). This observation
lends support to the hypothesis that the key amino acids
control the speciﬁcity through direct interactions with the
substrate.
CYP450 modeling is a vast and active area of research.
The structure presented here is a homology model of
a mammalian CYP450 based on the ﬁrst experimental
structure of another mammalian CYP450; however, it
follows a long line of previous modeling work targeting
CYP450s. Before the x-ray crystal structure of CYP2C5
FIGURE 1 Sequence alignment of CYP2A4, CYP2A5, and CYP2C5.
Residues experimentally shown to modulate substrate speciﬁcity (Ala-117,
Leu-209, Leu-365, and Val-481 in CYP2A4) are shown in gray (Negishi
et al., 1996). Thr-305, conserved in bacterial and mammalian CYP450s, is
also highlighted. The alignment was performed using Clustal X (Thompson
et al., 1997). Helices and b-sheets are labeled with letters h and b,
respectively. Additionally, helices A-L are identiﬁed, and residues
comprising b-sheets are labeled in italics (as assigned by Williams et al.,
2000a).
TABLE 1 Relative 2A4/2A5 substrate activity (Negishi et al.,
1996b)
Amino acid position Hydrolase activity*
P450y 117 209 481 DHEA Coumarin Testosterone
mP450 2A5 Alaz Phe Ala 7b-OH Low Low
sP450 2A5 Ala Phe Ala — Low Low
dP450 2A5H Val Phe Ala 2a-OH High Low
dP450 2A5L Ala Phe Ala 7b-OH Low Low
dP450 2A4 Ala Leu Val 7a-OH nd§ High (15a)
*High (H) testosterone C15-a-hydrolase activity of dP450 2A4 is 30-fold
greater than the low (L) activity in P450s 2A5.
yStrains described in Negishi, et al., 1996b.
zThe bold amino acids are the unique residue(s) mutation of which will
change speciﬁcity.
§Activity not detected by experiment.
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became available, molecular modeling studies of mamma-
lian CYP450s were based primarily on their structural
similarities to bacterial CYP450s. These studies aimed to
map out the active site by building homology models to
understand the structural causes underlying substrate
speciﬁcity. Homology models made use of sequence
alignment, and were challenged by the low sequence identity
between mammalian and bacterial CYP450s (Dai et al.,
2000). Such studies include the homology model of human
CYP4A11 (Loew and Chang, 1999), the two subfamily
(Lewis and Lake, 1995; Lewis et al., 1999) and one
subfamily (Dai et al., 1998) to name a couple. Rather than
focus exclusively on the active site, the model presented here
is based on simulations under periodic boundary conditions
on nanosecond time scales of all atoms in the system. Long-
range interactions and solvation effects are accounted for,
yielding a more complete, dynamical picture of the enzyme.
CYP2A4 presented a special challenge to long time
simulation because there are no stabilizing intramolecular
disulﬁde bridges, and the heme is noncovalently bound.
COMPUTATIONAL PROCEDURE
Model building
The x-ray crystal structure of CYP450 2C53LV_dH (pdb
code: 1DT6), which is CYP2C5 modiﬁed to increase
solubility, served as a template for building CYP2A4
(Williams et al., 2000). The CYP2C5 x-ray crystal structure
did not contain a ligand, nor was water detected in the
substrate-binding cavity. A sequence alignment between
CYP2C5 and CYP2A4 was performed (Fig. 1). The
sequence of CYP2A5, which differs by only 11 residues
from CYP2A4, was also included in the alignment. The
sequence identity between CYP2C5 and CYP2A4 is 54%
(for all residues). Before homology modeling, the CYP2C5
x-ray crystal structure was minimized in vacuum using
AMBER (Case et al., 1999). Only side chains and hydrogen
atoms (which were added to the crystal structure) were
minimized for 10,000 steps, using a combination of steepest
descent and conjugate gradient procedures. To preserve the
initial backbone conﬁguration of the x-ray crystal structure,
no backbone atoms were allowed to move until the
homology modeling was complete. The energy-minimized
structure was gradually mutated into CYP2A4, a few
residues at a time, using the Biopolymer module of SYBYL
6.5 (Tripos, St. Louis, MO). The mutated side chains were
hydrogenated, and each set of mutations was followed by
a local minimization of the mutated side chains and
surrounding residues to alleviate steric conﬂicts. A total of
215 side chains were mutated. The fully mutated structure
was superimposed on the x-ray crystal CYP2C5. The root
mean square deviation (RMSD) of the backbone atoms was
0.1 A˚ , indicating that the perturbation of the backbone was
negligible. At this point, additional residues were added to
the model CYP2A4 using homology modeling. Speciﬁcally,
amino acid residues 216-226 (FG loop) and 280-282 (gap in
the sequence alignment) were modeled using the loop search
algorithm in SYBYL 6.5. Finally the hydrogens and side
chains of the model CYP2A4 were again minimized in
vacuum for 100,000 steps, beginning with 5,000 steps of
steepest descent minimization. All minimization cycles
employed a nonbonded cutoff of 8 A˚ , with the nonbonded
list updated at every step.
The Fe atom of the heme is hexavalent, coordinated by the
sulfur atom of Cys-439 in the ﬁfth axial position, and by an
oxygen atom in the sixth axial position. The iron oxygen was
absent from the x-ray crystal structure. Its addition to our
CYP2A4 model was intended to guide the positioning of the
ligand, and to reﬂect the active oxygen intermediate of the
heme. The existing parameters and charges for this in-
termediate were used. These were previously developed to
be consistent with the AMBER force ﬁeld (Harris and Loew,
1995).
Molecular dynamics simulation
The energy-minimized model was evaluated with PRO-
CHECK,which detected no steric conﬂicts. Subsequently, the
system was solvated in a box of 16,867 TIP3P water
molecules (Jorgensen et al., 1983). The walls of the box were
initially located 12 A˚ from any protein atom. The initial size
of the solvent box was 94.9A˚ 3 90.8A˚ 3 78.1A˚ . Three
chloride counterions were added to keep the system
electrically neutral during the simulation, bringing the total
number of atoms in the system to 56,762. The simulation in
solution was performed under periodic boundary conditions.
The solvated CYP2A4 structure was energy minimized in
solution. A stepwise energy minimization protocol was
applied: the relaxation of the solvent molecules and counter-
ions was followed by additional energy minimization of the
solvent, counterions, and hydrogen atoms of the protein, and
the side chains, for 30,000 steps. After minimization, the
RMSD of the backbone atoms of the model with the CYP2C5
structure was 0.6 A˚ .
The system was then gradually heated from 0 K to 300 K
in the course of constant-volume dynamics. Once the tem-
perature reached 300 K, additional equilibration at constant
volume and temperature was performed for 20 ps. During the
entire constant volume run, the backbone was ﬁxed by
invoking the belly option in AMBER. However, when the
production run at constant pressure was initiated, the belly
option was removed as it sometimes may lead to stability
difﬁculties when used with constant pressure algorithms.
Instead, the backbone was kept ﬁxed with Cartesian re-
straints, and then gradually relaxed by slowly reducing the
force constant from 5.0 to 0 in the course of the initial 100 ps
of dynamics.
This procedure was adopted after an earlier simulation,
performed without the gradual relaxation of the backbone,
resulted in a structure with major backbone deviations.
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Although a degree of rearrangement in the backbone of the
protein is expected for a homology model undergoing a long
dynamical simulation, we found that the deviations observed
in our model resulted in the loss of certain elements expected
to be well- conserved. Most importantly, the heme exhibited
a large motion (on the order of 4 A˚ ) away from the I helix.
This motion resulted in a partial unraveling of the L helix,
situated directly under the heme. Additionally, the distances
between the four catalytic amino acid residues and the heme
differed greatly from the corresponding distances in the x-ray
crystal CYP2C5. On the basis of this observation, the initial
model of CYP2A4 was carefully reequilibrated with the
procedure presented here. The resulting distances between
the four catalytic residues and the heme, reported in our
work, signify an improved model where the key elements are
conserved.
After this point, the simulation was unconstrained, with
the exception of the SHAKE algorithm employed to freeze
out the vibrational motion of the hydrogen atoms (Ryckaert
et al., 1977). The time step was 1 fs. The particle mesh Ewald
summation was used to account for long-range interactions
(Darden et al., 1993; Essman et al., 1995). The coordinate
ﬁles were written and saved at every 5 ps. A trajectory of 3 ns
was obtained.
Substrate docking and simulation of
substrate-bound CYP2A4
The x-ray crystal structure of testosterone was obtained from
the Cambridge Crystallographic Database (CSD reference
code TESTON10). The geometry of the testosterone
molecule was optimized with the Hartree-Fock method,
employing the 6-31G* basis set in Gaussian 98 (Frisch et al.,
1998). A set of RESP charges was ﬁtted onto the optimized
geometry of testosterone (Bayly et al., 1993). The AMBER
force ﬁeld parameters of testosterone were assigned by
analogy. The testosterone ligand was manually docked into
the binding site of CYP2A4. An equilibrated structure of
CYP2A4 after 1 ns dynamics, with solvent molecules re-
moved, was used. The ligand was initially placed in the
active site so that the atoms of the ligand were no closer than
2.3 A˚ to any of the backbone atoms. This procedure ensured
that no drastic perturbations to the backbone structure would
be introduced as a result of ligand docking and subsequent
energy minimization. The docking procedure placed the
hydroxylated carbon C15 at 3.5 A˚ from the ferryl oxygen.
Steric clashes between the ligand and protein atoms were
alleviated with several minimization cycles in vacuum.
Initially, the side chains of the active site residues (those
within a 7 A˚ radius of the ligand) were energy minimized. In
the second pass of energy minimization, all protein side
chains were allowed to move. At this point, the backbone
and the ligand remained ﬁxed. The resulting structure was
resolvated in a box of TIP3P water molecules. Three chloride
ions were added to neutralize the charges of the system. The
solvated system was once again equilibrated following the
procedure described above, and a dynamics simulation was
performed at constant pressure. During the heat-up and
constant volume equilibration phases, the backbone atoms
were kept ﬁxed with belly constraints. For the constant
pressure dynamics run, the belly constraints were released,
and instead a Cartesian constraint was introduced for the
backbone atoms and the ligand, for the initial 100 ps of the
simulation. In the remainder of the simulation, the backbone
was unconstrained. Instead a harmonic constraint was
introduced between the atom C15 of the ligand and the
ferryl oxygen of the heme. The constraint was used to
gradually reduce the distance between these two atoms to 2.9
A˚ . This procedure allowed the testosterone ligand to explore
rotational degrees of freedom while preserving the expected
catalytic distance between the active oxygen and the
activated carbon. The duration of the constant pressure
simulation was 2 ns, at 300 K and with the time step of 1 fs.
Additionally, a 1 ns simulation was performed, with no
distance constraints on the ligand, and following the same
protocol as described above.
The coordinate ﬁles for the 2A4 and 2A4/T models are
available from the authors on request (lee_pedersen@unc.
edu).
Helix analysis
The distortion of the I helix was analyzed with the secondary
structure analysis program DSSP (Kabsch and Sander;
1983), by methods similar to those suggested in a study of
protein a-helices (Kumar and Bansal, 1998) and from an
algorithmic study of helices (Christopher et al., 1996). The
central idea is that by deﬁning a bisector of the angle formed
by three consecutive a-carbons at two nearby locations,
a local helix direction vector can be found from the cross
product of the bisector vectors. Repeating this procedure at
another location on the helix deﬁnes the helix direction at
that location. The dot product of the two local helix direction
vectors then provides the angle between the two directions.
We chose eight sets of four Cas at each end of the I helix to
compute an average angle for the I helix.
RESULTS AND DISCUSSION
General evaluation of the model
The stability of the protein during dynamics was ascertained
by calculating the RMSD of the backbone atoms during the
course of the 3 ns simulation (Fig. 2). The initial energy-
minimized CYP2A4 model served as a reference. As
expected for a homology model with only 54% sequence
identity (215 residues mutated), the structure evolved
signiﬁcantly from its starting conﬁguration. However, the
conserved core of helices I, J, L and the Cys pocket (residues
433-437) was expected to remain more stable than the rest of
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the protein throughout the simulation. The RMSD of the
amino acid residues comprising the core of the enzyme was
also evaluated. Whereas the RMSD of all backbone atoms
leveled off at 2.5 A˚ , the core residues exhibit a RMSD
of only 1 A˚ . Additionally, these core structural elements
equilibrated much earlier in the simulation than the rest of the
protein. Therefore, the enzyme core appears to be better
structurally conserved than the remainder of the residues.
This observation is in agreement with previous predictions
(Hasemann et al., 1995).
The RMSD of individual helices was measured with the
core elements aligned, over the course of the 3 ns simulation
(results not shown). The largest difference was detected in
helices A (average RMSD ¼ 4.4 A˚ ), B (average RMSD ¼
3.5 A˚ ), G (average RMSD¼ 2.8 A˚ ), and F (average RMSD¼
1.8 A˚ ). The interior helices are expected to have a lower
deviation among various CYP450s than the external helices
(Hasemann et al., 1995). Additionally, for the CYP2C5 x-ray
crystal structure, the F helix and the N-terminus of the G
helix form crystal contacts with a symmetry-related molecule
(Williams et al., 2000a). The loss of these contacts upon
solvation may account for an increased motion of the F helix
and the N-terminus.
To validate the CYP2A4 model, it was compared not only
to CYP2C5, but also to the bacterial CYP450bm3, which is
the bacterial enzyme nearest in three-dimensional structure
to the mammalian CYP450 enzymes (Ravichandran et al.,
1993). Williams et al., reported small deviations in the core
regions of CYP450bm3 and CYP2C5. We performed an
alignment of the conserved core elements of the CYP450bm3
and CYP2A4. The resulting RMSD were compared to the
alignment of CYP450bm3 with CYP2C5 (Table 2). The
CYP2A4/CYP450bm3 deviations are slightly larger than the
corresponding CYP2C5/CYP450bm3 deviations, owing per-
haps to the expected increased mobility of the solvated
CYP2A4 structure.
A crucial feature for the proper functioning of CYP450s is
the positioning of the heme group in the active site. Salt
bridges between the active pocket residues and the pro-
pionate groups of the heme serve to accommodate these
negatively charged groups in the largely hydrophobic
environment of the pocket. Hydrogen bonding to the
propionate groups of the heme was examined during the
ﬁnal 1 ns of the 3 ns simulation. Four amino acids (Arg-128,
Arg-372, Ser-433, and Arg-437) maintain hydrogen bonding
contacts to the propionate oxygens of the heme (Fig. 3).
These contacts are conserved at corresponding positions in
CYP2C5 (Williams et al., 2000a). A ﬁfth hydrogen bond
found in CYP2C5, between the propionate side chain of the
D ring and the side chain of Trp-120, is not conserved in the
CYP2A4 model. The residue at the corresponding position in
CYP2A4 is Ala.
Another feature of the CYP2A4 structure that is conserved
in CYP2C5, CYP450cam, and CYP450bm3 is the hydrogen
bond between the side chain of Thr-305 and the carbonyl
FIGURE 2 Root mean square deviations of backbone atoms of CYP2A4.
The RMSD of all backbone atoms, including loops, converged at 2.5 A˚
(solid ), whereas the RMSD of the conserved core (helices I, J, and L and the
Cys-pocket) converged at 1 A˚ (small circles).
TABLE 2 Root mean square deviation (A˚) of the enzymatic core
(helices I, J, and L) among CYP2A4, CYP2C5, and CYP450bm3,
the bacterial enzyme most closely resembling mammalian
CYP450s
CYP450bm3 helix RMSD with CYP2A4, A˚ RMSD with CYP2C5, A˚
I 0.79 0.73
L 0.84 0.53
J 0.40 0.53
I, J, L 1.50 1.05
FIGURE 3 Hydrogen bonding contacts between protein residues and
propionate oxygens of the heme. Arg-128, Arg-372, and Arg-437 form salt
bridges to the propionate groups via main-chain and side-chain hydrogen
atoms, and the side chain of Ser-433 forms a hydrogen bond to the
propionate oxygen. Only hydrogen atoms involved in salt bridge/hydrogen
bonding are shown.
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oxygen of Ala-301. Thr-305 has been implicated in the
delivery of a proton from the exterior of the protein to the
reduced oxygen intermediates. This hypothesis was sug-
gested by the bulge of the central I helix in the region
containing the conserved Thr, observed in all three bacterial
CYP450s (at position 252 in CYP450cam). Along with this
helical disruption, a hydrogen bond appeared invariably
between the Thr and a residue four positions away, in the
direction of the N-terminus to satisfy the lost hydrogen
bonds in the helical deformation. In particular, a recent study
of the CYP450cam active site showed that the mutation Thr-
252-Ile decreased the monooxygenase activity 10-fold
(Hishiki et al., 2000). The bulge of the central I helix is
also observed in the CYP2A4 model, with Thr-305 located at
the end of the resulting bulge. This helical distortion is,
however, not evident in the CYP2C5 x-ray crystal structure.
It has been proposed that the I helix bulge forms to
accommodate the dioxygen bound to the heme iron. In the
CYP2A4 model, only one oxygen atom is present. However,
its presence in close proximity to, and the resulting
interactions with, the surrounding residues of the I helix
may account for the development of the I helical distortion in
the CYP2A4 model. The possible functional signiﬁcance of
the I helical bulge will be revisited in a discussion on the role
of water in the substrate binding cavity.
The deviation of Ca atoms of the solvent-equilibrated
CYP2A4 from their original positions in the x-ray crystal
CYP2C5 was used as a measure of structural difference
between these two enzymes (Fig. 4). The regions of
CYP2A4 that deviate most signiﬁcantly from the x-ray
crystal structure were identiﬁed. The backbone atoms of the
conserved core of CYP2A4 and CYP2C5 were aligned for
this comparison. As expected, the most mobile regions were
the residues in the loops, and especially those comprising
a turn. The N-terminus of the protein was particularly
mobile, due to the fact that residues of CYP2C5 correspond-
ing to residues 42-64 in CYP2A4 were involved in a crystal
contact. A signiﬁcant deviation was observed for the C-
terminus of the A helix, the random coil containing SRS1,
the N-terminus of the G helix and the F helix (also involved
in a crystal contact (Williams et al., 2000a)), the FG loop,
and several fragments of interhelical loops (120-122, 141-
142, 337-338, 381-384, 401-408, 419-421, and 465-474).
The residues in the Cys-pocket of CYP2A4 (residues 433-
437) are located ;2.2 A˚ from the x-ray crystal structure
positions of CYP2C5. This displacement is due in part to the
mutation of Val-433 (CYP2C5) to a Phe-440 in CYP2A4.
The mutation to a bulkier, more hydrophobic side chain,
although removed by several residue positions from the
region of greatest deviation, may have necessitated some
backbone rearrangement that propagated to the neighboring
residues. An alignment of several CYP450 family 2 proteins
(Gotoh, 1992) shows that CYP2A4/2A5 enzymes are unique
in having a Phe at position 440. In other enzymes, a residue
with a smaller side chain (a Leu or Val) occupies this posi-
tion. Therefore the subsequent rearrangement of the Cys-
pocketmay be a unique aspect of theCYP2A4/2A5 geometry.
The secondary structure evaluation program DSSP was used
to ascertain that the secondary structure elements (speci-
ﬁcally the helices) were preserved in the 3 ns model.
PROCHECK was used to evaluate the overall quality of the
3 ns structure. The overall G-factor score was 0.2, which
falls within the range of expected values. The correspond-
ing score for the x-ray crystal structure CYP2C5 was
slightly better, at 0.01 (values of under 0.5 are considered
poor) (Laskowski et al., 1993).
Comparison of CYP2A4 and CYP2C5
Once the overall stability of the CYP2A4 model in solution
was ensured, the differences between the active sites of
CYP2A4 and CYP2C5 were assessed, initially in the
absence of the ligand. The substrate binding site in CYP450s
is hemispherical, with the heme forming the base and the I
helix one side. In the course of the simulation, the heme in
the model CYP2A4 has moved by ;1.5 A˚ from its original
position in the CYP2C5 crystal structure, in a direction away
from the center of the I helix. Once the structure is
equilibrated in solution, the amplitude of this displacement
actually ﬂuctuates between 1 A˚ and 2 A˚ throughout the
simulation. As described above, this displacement is not
sufﬁcient to break the hydrogen bonding contacts that anchor
the heme in the active site. However, it induces some
rearrangement in the surrounding amino acid positions. We
focused speciﬁcally on the four residues that play a role in
substrate binding and activation: Leu-209, located at the
C-terminus of the F helix; Ala-117, in the BC loop; Val-481
in the turn between beta strands; and Leu-365 in the region
between the K helix and a b-sheet. Additionally, the position
of Thr-305, located in the bulge of the I helix, was
considered, because of that residue’s possible role in proton
FIGURE 4 Ca deviation between x-ray crystal CYP2C5 and solvent
equilibrated CYP2A4. The deviation of the Ca positions was calculated after
backbone atoms of the core residues of CYP2C5 and CYP2A4 (snapshot
after 3 ns of dynamics) were superimposed. The gaps in the plot correspond
to the regions missing in the x-ray crystal structure: the unresolved segment
of the FG loop (residues 216-226) and the gap resulting from the alignment
with CYP2A4 (residues 280-282).
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transfer. To assess the positions of these amino acids relative
to the heme, the distances between their Ca and Fe of the
heme were compared to the corresponding distances in
CYP2C5 (Table 3). We ﬁnd that the largest deviation (less
than 2 A˚ ) is consistent with the displacement of the heme in
CYP2A4 relative to its position in CYP2C5.
Comparison of the substrate-free and
substrate-bound forms of CYP2A4
The solvent equilibrated substrate-free CYP2A4 model may
be compared to the equilibrated model of CYP2A4 with the
substrate (testosterone) bound (CYP2A4/T). The RMSD of
all backbone atoms between the two ﬁnal structures was 2.7
A˚ . The core helices I, J, and L were found to deviate with 1.4
A˚ RMSD between the two model structures. The cause of the
deviations is apparent when the binding pocket is examined,
as the substrate binding induces some backbone and side-
chain rearrangement.
The residues within a contact distance (4 A˚ ) from any of
the testosterone atoms were considered. Snapshots of the
dynamical trajectory were examined at each 50 ps during
a 500-ps time period. The following residues were con-
sistently identiﬁed to be within contact distance of the ligand:
Arg-101, Glu-103, Phe-107, Ala-117, Phe-118, Leu-209,
Thr-212, Ala-213, Asn-297, Phe-300, Ala-301, Glu-304,
Thr-305, Leu-370, Ala-371, Arg-437, Phe-480, and Val-481.
The backbone atoms of these residues were then used to
superimpose CYP2A4 and CYP2A4/T (RMSD ¼ 1.7 A˚ ).
When this superimposition was performed, the heme units in
the two molecules were overlayed almost exactly. This
conﬁguration therefore gives an indication of the motion of
the ligand binding residues with respect to the heme and the
ligand. The Ca deviations of those amino acids in contact
with the ligand were measured to determine how much
displacement was caused by the presence of the ligand. The
two active sites are compared in Fig. 5. Several side chains
found within 4 A˚ of testosterone that experienced signiﬁcant
change are shown. Additionally, the backbone of residues
101-103 shifts nearer to the ligand. The Ca deviations for
these three residues from their positions in the ligand-free
form were, respectively, 1.5 A˚ , 1.9 A˚ , and 2.6 A˚ . Glu-103
has moved toward the interior of the cavity (although its
negatively charged side chain still points away from the
cavity). On the contrary, the hydrophobic Phe-107 side chain
undergoes a rotation toward the ligand (the Ca deviation of
Phe-107 was 1.0 A˚ ). Residues 117 and 118, located in the
BC loop, are especially interesting because Ala-117
inﬂuences the catalytic activity of the CYP2A4 enzyme
(Table 1, Negishi et al., 1996c). The backbone atoms of these
two residues deviated from their position in CYP2A4 by 1.8
A˚ , moving nearer the substrate in the ligand-bound form.
This motion was most likely caused by steric repulsion,
because the bulky side chain of Phe-118 was originally
situated close to the interior of the active site, partially
blocking the substrate binding cavity. The addition of the
ligand and the subsequent energy minimization led to
a rotation of that side chain away from the cavity interior.
During the course of the simulation, Ala-117, Leu-209,
Thr-305, and Val-481 directly interact with the ligand (Fig.
6). The binding pocket for the simulations with a single
constraint (Fig. 6 A) and without constraints (Fig. 6 B) are
shown. The side chain of Ala-117 is near atoms C4-C6,
including the keto group of testosterone. Leu-209 is near the
hydroxyl group of the ligand. The position of the Leu-209
side chain ﬂuctuates in the course of the simulation;
however, for a signiﬁcant period its side chain is within
4 A˚ of C12 of the ligand. The side chain methyl group of
Thr-305 interacts with testosterone via a hydrophobic
contact with C16, whereas Val-481 is positioned so as to
TABLE 3 Location of functionally critical amino acids in the
active sites of the solvent equilibrated model CYP2A4, CYP2A4/T
(unconstrained ligand), and the x-ray crystal structure of
CYP2C5 (Williams et al., 2000a)
Residue
Distance from Fe
in CYP2C5, A˚
Distance from Fe
in CYP2A4, A˚
Distance from Fe
in CYP2A4/T, A˚
Ala-117 9.2 10.7 10.7
Leu-209 13.5 13.4 17.3
Thr-305 6.8 8.6 7.2
Leu-365 10.5 10.6 11.9
Val-481 11.3 10.2 11.7
The distances in A˚ between Ca and the heme iron are listed.
FIGURE 5 The active site of solvent equilibrated CYP2A4 (light) and
CYP2A4/T (dark). Only the residues lining the active site (within 4 A˚ of the
docked testosterone in CYP2A4/T) that showed signiﬁcant change are
shown. The hemes of the two structures were overlaid; only the CYP2A4/T
heme is shown.
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make a hydrophobic contact with one of the testosterone
methyl groups (C18). Leu-365 is the only catalytic amino
acid with no direct interaction with the ligand. However, its
neighboring residue, Ile-366, occasionally moves within 4 A˚
of the ligand in the course of the simulation, suggesting the
possibility of an indirect effect of Leu-365 on the binding of
the ligand. These hydrophobic contacts are also observed in
the simulation with no distance constraints on the ligand
(Fig. 6 B). As the ligand moves away from the heme (the
equilibrium distance between C15 and the ferryl oxygen is
now 4.0 A˚ ), the distance between Leu-209 and C12 remains
unchanged whereas that of Val-481 and C18 decreases.
Although the constrained simulation preserves the favorable
orientation between the ferryl oxygen and C15 of testoster-
one, the position of the ligand obtained in the unconstrained
simulation agrees better with previous experimental results.
Iwasaki et al. (1993), showed that the combination of the
residue 209 and the substituent at position C11 of the ligand
alter substrate binding speciﬁcity at the active sites of
CYP2A4 and CYP2A5. Their results indicate that the
interaction of 11-b-hydroxysteroids inhibits testosterone
15-a-hydroxylase activity when the residue at position 209
is Asn, although 11-deoxysteroids inhibits testosterone 15-
a-hydroxylase activities regardless of the nature of the
residue at position 209. In the unconstrained simulation (Fig.
6 B), the side chain of Leu-209 is located nearer to the C11
position than in the constrained simulation (Fig. 6 A), and
can potentially interact with an 11-b-hydroxy substituent on
the ligand. Additionally, the location of the ligand farther
from the heme, as the unconstrained simulation indicates,
may reﬂect the more favorable conﬁguration of the substrate
upon binding to the enzyme, but before the hydroxylation
reaction. A shift of the substrate position toward the heme
may occur as a consequence of the electron transfer to
CYP2A4 from its redox partner, NADPH-binding reductase,
which CYP2A4 requires for catalysis. A movement of the
bound substrate 6 A˚ in the direction of the heme, which
positions it for the hydroxylation reaction, was observed in
CYP450bm3 complexed with reductase as a consequence of
the ﬁrst electron transfer (Modi et al., 1996).
In the equilibrated constrained ligand simulation, the
ligand is hydrogen bonded at the keto end (to the backbone
oxygen of Phe-118). In the equilibrated unconstrained ligand
simulation, however, this hydrogen bond is broken. Instead,
the keto group becomes hydrogen bonded to a water
molecule that itself interacts with a heme propionate group
and with the side chains of R117 and R437. The hydroxyl
end of the ligand, interacts hydrophobically with L209,
A213, and E304 (on the I helix). Overall, testosterone is
anchored in the active site/binding pocket by hydrophobic
interactions.
A measure of the degree of rearrangement of the binding
pocket/active site on ligand binding is seen (Table 3) from
the changes in the distances of the a-carbon of key residues
from the Fe atom. The presence of ligand does not affect
A117 but L209, V365, and V481 are at larger distances.
T305 actually moves nearer (by 1.4 A˚ ) to the Fe.
The FG loop
The loop connecting the helices F and G has been attributed
a key role in controlling the substrate access into the active
site of CYP450s. In bacterial CYP450s, the FG region has
very high B-factors compared to the rest of the structure,
suggesting that the ﬂexibility of this loop allows it to close
and open the entrance to the substrate binding site
(Hasemann et al., 1995). In CYP2C5, a 10-residue portion
of the loop had ambiguous electron density, but was
predicted, due to the crystal lattice constraints, to ﬁll the
space between the N-terminal b-sheets and F and G helices
(Williams et al., 2000a). In the solvent-equilibrated CY-
P2A4, in both substrate-free and substrate-bound forms, the
FG loop assumes the predicted conformation, ﬁtting between
the ends of the F and G helices and the system of b-sheets.
The mobility of the FG loop is restricted by hydrogen
bonding contacts to the residues of the b-sheet. In the
CYP2A4/T (both constrained and unconstrained models),
Gln218 makes a strong hydrogen bond to Ala-371 and Glu-
390 (Fig. 7). In the substrate-free CYP2A4, Gln-218 instead
hydrogen bonds to Arg-372. These hydrogen bonds anchor
the FG loop, and as a result, it does not exhibit extensive
motion in the course of the simulation. The ﬂuctuations of
the FG loop were evaluated by calculating an average Ca
deviation for the residues of this loop while helices F, G, and
the conserved core were aligned. A comparison of a snapshot
early in the simulation with the ﬁnal snapshot of CYP2A4
revealed an average Ca deviation of 1.56 A˚ (Fig. 8 A). The
average Ca deviation of the FG loop of solvent equilibrated
CYP2A4/T from the early snapshot of CYP2A4 was 2.75 A˚
(Fig. 8 B). A recent study of CYP450cam demonstrated that
the opening of the substrate access channel in this enzyme is
FIGURE 6 The location of residues Ala-117, Leu-209, Thr-305, and Val-
481 with respect to the ligand in (a), the simulation with the distance
between C15 of testosterone and the ferryl oxygen constrained, and (b), the
simulation with no distance constraints. The distances, in angstroms,
between side-chain carbons of these residues and the heavy atoms of
testosterone, are indicated. The keto group of testosterone points toward
Ala-117. C11, C12, and C15 are labeled in (a).
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facilitated by the motion of the F and G helices, which
retracts the FG loop from the b-sheet domain, and induces
some conformational changes in the I helix (Dunn et al.,
2001). The conﬁguration of the FG loop in the model
CYP2A4 and CYP2A4/T resembles the closed state of the
CYP450cam. The corresponding open state, which would
have been signaled by the FG loop retraction away from the
b-sheet domain, was not observed in our simulation. Partly
this is due to the induced ﬁt methodology employed in
docking the substrate. Testosterone was placed directly in the
active site, and the surrounding protein residues were relaxed
to accommodate the ligand. A dynamical simulation with the
substrate guided into the interior of the protein through an
entrance channel, similar to those performed by Lu¨demann et
al., may be necessary to induce the transition from the closed
to the open conformations of CYP2A4 (Lu¨demann et al.,
2000a,b).
Water in the interior of solvent
equilibrated CYP2A4
Because water has been implicated in the mechanism of
activation of substrates by P450s, it is imperative to examine
the water molecules in the active site/binding pocket region
for our simulations. The x-ray crystal structure (Williams
et al., 2000a) was not of sufﬁcient resolution (3.0 A˚ ) to ‘‘see’’
water molecules that were likely present, although some
residual density in the region was thought to be due to an
unidentiﬁed ligand.
At the end of the 3 ns simulation of CYP2A4 in solution,
four waters were detected in the interior of the enzyme and
less than 10 A˚ away from the oxygen of the heme. The water
diffusion from bulk to the ﬁnal location in the interior of
CYP2A5 was tracked by mapping consecutive snapshots of
these four water molecules in the course of the simulation.
The resulting paths identify at least three entrance channels
for water. As the water molecules are much smaller than any
CYP450 substrate, the water entrance pathway may not be
indicative of a substrate access channel. Water molecule 1
enters the enzyme between helix F and residues 476-486,
which form the C-terminal segment after helix L. Two water
molecules (2 and 3) are located near one another, in the
proximity of the C ring of the heme. Water molecule 2 forms
hydrogen bonds to the backbone oxygen of Val-178 of the E
helix, and to the side chain of Glu-448 of the L helix. The
neighboring water molecule 3 also hydrogen bonds to the
side chain of Glu-448, and additionally, the two waters are
sufﬁciently close to bond to each other. Water molecule 2
and water molecule 3 follow the same path, entering between
the L helix and the E helix. Finally, water molecule 4 resides
close to the propionate groups of the heme at the end of the 3
ns simulation, where it forms hydrogen bonds with the
backbone oxygen of Leu-370 and the side chain nitrogen of
Arg-437. Water molecule 4 appears to enter the interior of
the protein between helix C and the BC loop. Only one of the
interior water molecule (water molecule 1) enters the active
site cavity. It is located 6.5 A˚ from the heme oxygen, near the
bulge of the I helix, where it forms hydrogen bonds to the
backbone nitrogen atoms of Thr-305 and Glu-304 of the I
helix, and the backbone oxygen atoms of Ala-235 and Phe-
234 of the H helix (Fig. 9). The importance of a water
molecule in this position has been described for the bacterial
CYP450 enzymes, where the conserved Thr, the neighboring
acidic residue, and the water in the groove of the I helix are
believed to comprise the essential elements of a proton
transfer network (Hasemann et al., 1995). Speciﬁcally, in
CYP450bm3, the proton was proposed to be transferred to
the heme from the side chain of the conserved Thr, which
was protonated by a water molecule. The acidic residue
neighboring the conserved Thr could in turn protonate the
water molecule (Ravichandran et al., 1993). In CYP450cam,
the side chain of the conserved Thr is oriented so as to make
FIGURE 7 Position of the FG loop in solvent equilibrated CYP2A4/T.
The FG loop is anchored between the ends of helices F and G and the b-sheet
by strong hydrogen bonds formed by residues Gln-218, Ala-371, and
Glu-390.
FIGURE 8 Motion of the FG loop. The coordinates of (a), the ﬁnal
CYP2A4 model (dark), and (b), the ﬁnal CYP2A4/T model (dark), were
superimposed onto the coordinates of CYP2A4 (light) early in the
simulation. Helices F, G and the conserved core were used for the
alignment. The FG loops exhibit moderate ﬂuctuations in both cases.
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a hydrogen bond to the sixth ligand of the heme. This,
however, is not the case in CYP450bm3 or CYP450terp, where
instead a carbonyl oxygen is located closest to the sixth axial
ligand (Hasemann et al., 1995). In the solvent equilibrated
CYP2A4, the water reaches its position near the I helical
bulge in the latter third of the 3 ns simulation.
It is clearly of interest to relate, if possible, the degree of
the bulge in the I helix to the presence or absence of ligand
and/or to the water molecule with binds near the bulge. Such
a possible relationship was suggested by Haines et al. 2001,
who noted in their x-ray crystal work the difference in water
coordination in a ligand-bound BM3 (pdb ¼ 1JPZ) and the
corresponding ligand-free BM3 (pdb ¼ 1BU7). Fig. 10 (a
and b) show the disposition of the T305 locality of the I helix
for 2A4 and 2A4/T (unconstrained), respectively. There is no
water bound in the ligand unconstrained case. Fig. 10 (c and
d) show the same view for BM3 (no ligand, 1BU7) and BM3
(ligand bound, 1JPZ). Remarkably, the nature of the H2O
binding in BM3 (no ligand, 1BU7) and the water molecule in
2A4 (no ligand) are similar. The evolution of this water
molecule path in 2A4 (no ligand) from initially outside the
protein shell to a binding pattern recognizable from that of
the BM3 (1BU7) suggests that the overall force ﬁeld is doing
very well in representing the local dynamics of water and its
interactions with proteins. Different ligands are present in
2A4/T (ligand bound (b)) and in BM3 (ligand bound,
1JPZ(d)). This difference perhaps accounts for the unlike
structures present around the T305 site: BM3 (1JPZ) has two
molecules of water bound in a form different than seen in
Fig. 10 a or c and 2A4/T (ligand bound(b)) has no water
bound.
Table 4 summarizes structural parameters for the I helix
for the 2C5 x-ray crystal structure, for the simulation
structures (bound and unbound) and for three BM3 crystal
structures. The helix angle (see Methods), the classiﬁcation
of nonhelical residues by the standard DSSP program
(Kabsch and Sander, 1983), the Fe-T305 distance, and the
distance between the ends of the I helix are computed. The
helix angle for the ligand bound cases (2A4/T, 1JPZ) is
slightly larger than the ligand-free (2A4, 1BU7 and 1HP D)
cases. An opposing correlation was reported by Haines et al.
2001, for the BM3 case (bound 1JPZ versus unbound
1BU7)—the difference may depend on what sections of the
helix are used to compute the angle. We used residues at
either end of the helix; if residues on either side (and near)
the T305 site are used, angles near those reported by Haines
et al. 2001, are found. Our protocol yields a helix angle of
8.18 for the 2C5 x-ray crystal structure. Unfortunately, we do
not know if water is bound at the bulge site or what ligand (if
any) is bound. We also computed these same properties for
a set of four P450cam structures (pdb: 5CP4, 5CPP, 1K2O,
and 1PHC) (results not shown). Three of these structures
have water bound at the bulge site and have ligand bound,
although one (1PHC) has neither. All have helix angles in the
FIGURE 9 Water in the active site of the solvent equilibrated CYP2A4.
Two views shown illustrate the proximity of the water molecule (rendered)
to the I helix, and the residues in the I helical bulge, Thr-305 and Glu-304. FIGURE 10 Local structure near the I helix bulge for a) 2A4 (no ligand),
b) 2A4/T (ligand unconstrained), c) BM3 (1BU7, no ligand), and d) BM3
(1JPZ, ligand).
TABLE 4 Comparison of I helix parameters from structural
analysis of bacterial, mammalian, and simulation pdb ﬁles
Structure Ligand
Water
Complex
Helix
Angle* DSSPy FeT(N)z
Ca-Ca§,
Nres{
Mammalian and simulation
1DT6|| yes not
resolved
8.1 6 2.7 0 9.43 46.6, 31
2A4(sim) no yes 13.9 6 6.4 2 9.10 45.4, 30
2A4/T(sim) yes (no)** 22.5 6 13.1 0 7.71 45.0, 30
Bacterial-BM3
1BU7## no yes 15.3 6 4.5 0 7.76 45.8, 31
1JPZ§§ yes yes 17.3 6 4.6 2 7.64 47.1, 31
1HPD{{ no yes 15.4 6 4.2 0 7.76 47.0, 31
*See Methods: averaged over 11 Ca coordinates from each end of helix, in
degrees.
yKabsch and Sander, 1983: number of residues with nonhelix classiﬁcation
by DSSP in I helix.
zHeme Fe-conserved T backbone nitrogen distance (in A˚ ).
§Distance between Cas at end of I helix.
{Number of residues in I helix deﬁned by DSSP.
||Williams et al., 2000a: ligand not seen due to resolution but may be
present.
**Water not seen in I helix bulge region after 4 ns total simulation.
##Sevrioukova et al., 1999.
§§Haines et al., 2001.
{{Ravichandran et al., 1993.
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8-118 range; all are identiﬁed by DSSP as having a nonhelical
segment near the catalytic threonine. Because the calculation
of the helix angle is so dependent on where the deﬁning
stretches are chosen, we are reluctant to associate any
property, including water complex structure or even
function, to its magnitude.
Thus, although our simulations are provocative in that
they allow us to obtain a reasonable glimpse of the pre-
transition state structure, they are obviously not the last
word. Ultimately, quantum mechanical calculations that ac-
commodate the key components of the active site will be
required to unravel the sequence of events that take place in
P450 activation.
CONCLUSION
Mammalian cytochromes CYP450 present a challenge for
molecular modelers due to their great diversity and the
relative scarcity of experimental structural data. Though they
share a similar fold, the details of each structure, especially
the active site, are unique and contribute to the great
versatility of these enzymes. Previous modeling work has
been based on bacterial CYP450s, the sequences of which
are quite different from those of the mammalian CYP450s.
In this work, a model of mouse CYP2A4 based on an x-ray
crystal structure of another mammalian enzyme (CYP2C5) is
presented. The structure is modeled in solution on a multiple-
nanosecond time scale. Although the initial structure of
CYP2A4 requires extensive homology modeling, the core
of the enzyme containing helices I, J, and L remains well-
conserved throughout the simulation. The heme in the
solvent equilibrated CYP2A4 is located in such a way that
the salt bridges and hydrogen bonds between the heme and
the protein, observed in CYP2C5, are maintained in our
model. The docking of testosterone, a primary substrate of
CYP2A4, induced moderate rearrangements in the active
site. Mainly hydrophobic interactions guide the binding of
the ligand. A remarkable result is the natural evolution of
a water complex near the conserved I helix Thr. A similar
complex had been identiﬁed previously in a BM3 structure.
The local structure (including water) near the center of the I
helix and between it and the catalytic Fe depends on the
presence or absence of ligand.
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